Practices for managing a flare of long-standing rheumatoid arthritis: Survey among French rheumatologists

Clinical and Experimental Rheumatology

Volumn 23, Issue 1, 2005, Pages 36-42

  Maravic, Milka ^a,b   Bergé, Claude ^c   Daurès, Jean Pierre ^c   Boissier, Marie Christophe ^a  

^a AVICENNE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

Drug prescription; Evaluation; Rheumatoid arthritis; Survey

Indexed keywords

ANALGESIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FOLIC ACID; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; LIVER ENZYME; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROTON PUMP INHIBITOR; SALAZOSULFAPYRIDINE; TIOPRONIN; TUMOR NECROSIS FACTOR ANTIBODY; VITAMIN D;

ABSORPTIOMETRY; ADD ON THERAPY; ARTICLE; BLOOD CELL COUNT; CLINICAL PRACTICE; CONTROLLED STUDY; COST OF ILLNESS; CREATININE BLOOD LEVEL; DISEASE DURATION; DISEASE EXACERBATION; DRUG COST; ELBOW RADIOGRAPHY; FEMALE; FRANCE; HAND RADIOGRAPHY; HUMAN; KNEE RADIOGRAPHY; MALE; MEDICAL SPECIALIST; NECK PAIN; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SPINE RADIOGRAPHY; THORAX RADIOGRAPHY; WRIST RADIOGRAPHY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HEALTH CARE COSTS; HUMANS; MALE; METHOTREXATE; PHYSICIAN'S PRACTICE PATTERNS; PREDNISONE; QUESTIONNAIRES; RHEUMATOLOGY;

EID: 15844389496     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. JARVIS B, FAULDS D: Etanercept: a review of its use in rheumatoid arthritis. Drugs 1999; 57; 945-66.
2. MARKHAM A, LAMB HM: Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs 2000; 59: 1341-59.
3. KEYSTONE EC, KAVANAUGH AF, SHARP JT et al.: Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 2004; 50: 1400-11.
4. American College of Rheumatology Sub-Committee on Rheumatoid Arthritis Guidelines: Guidelines for the management of rheumatoid arthritis. 2002 update. Arthritis Rheum 2002; 46: 328-46.
5. RAT AC, BOISSIER MC: Rheumatoid arthritis: Direct and indirect costs. Joint Bone Spine 2004; 71: 518-24.
6. MARAVIC M, BERGÉ C, DAURÈS JP et al.: Survey of practices regarding management of early typical rheumatoid arthritis by rheumatologists in France. Clin Exp Rheumatol 2004; 22: 319-27.
7. CLARKE AE, ST-PIERRE Y, JOSEPH L et al.: Radiographic damage in rheumatoid arthritis correlates with functional disalibity but not direct medical costs. J Rheumatol 2001; 28: 2416-24.
8. YELIN E, TRUPIN L, WONG B et al.: The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis. J Rheumatol 2002; 29: 1851-7.
9. YELIN E, WANKE LA: An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. Arthritis Rheum 1999; 42: 1209-18.
10. SWINKELS RA, OOSTENDORP RA, BOUTER LM: Which are the best instruments for measuring disabilities in gait and gait-related activities in patients with rheumatic disorders. Clin Exp Rheumatol 2004; 22: 25-33.
11. REIJNIERSE M, BLOEM J, DIJKMANS B et al.: The cervical spine in rheumatoid arthritis: relationship between neurologic signs and morphology on MR imaging and radiographs. Skeletal Radiol 1996; 25: 113-8.
12. LAIHO K, SOINI L, KAUTIAINEN H et al.: Can we rely on magnetic resonance imaging when evaluating unstable atlantoaxial subluxation? Ann Rheum Dis 2003; 62: 254-6.
13. NEVA MH, ISOMAKI P, HANNONEN P et al.: Early and extensive erosiveness in peripheral joints predicts atlantoaxial subluxations in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 1808-13.
14. HAUGEBERG G, UHLIG T, FALCH JA et al.: Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000; 43: 522-30.
15. MORELAND LW, O'DELL JR: Glucosteroids and rheumatoid arthritis. Arthritis Rheum 2002; 46: 2553-63.
16. American College of Rheumatology ad hoc Committee on Glucocorticoid-Induced Osteoporosis: Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001; 44: 1496-503.
17. SOLOMON DH, KATZ IN, JACOBS JP et al.: Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 2002; 46: 3115-20.
18. WEINBLATT ME, WEISSMAN BN, HOLDSWORTH DE et al.: Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum 1992; 35: 129-37.
19. WEINBLATT ME, KAPLAN H, GERMAIN BF et al.: Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum 1994; 37: 1492-8.
20. MAINI R, St CLAIR EW, BREEDVELD F et al.: Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 1999; 354: 1932-9.
21. GENOVESE MC, BATHON JM, MARTIN RW et al.: Etanercept versus methotrexate in patients with early rheumatoid arthritis. Arthritis Rheum 2002; 46: 1443-50.
22. RAU R: Adulimumab (a fully human anti-tumour necrosis factor a monoclonal anti-body) in the treatment of active rheumatoid arthritis: the initial results of five trials. Ann Rheum Dis 2002; 61(Suppl II): ii70-ii73.
23. POPE JE, HONG P, KOEHLER BE: Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists. J Rheumatol 2002; 29: 255-60.
24. WARD MM: Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980-1995: results from the National Ambulatory Medical Care surveys. J Rheumatol 1999; 26: 546-50.
25. BLOMQVIST P, FELTELIUS N, EKBOM A et al.: Rheumatoid arthritis in Sweden. Drug prescriptions, costs and adverse drug reactions. J Rheumatol 2000; 27: 1171-7.